Small molecule-mediated targeting of microRNAs for drug discovery: experiments, computational techniques, and disease implications

Sun, J; Xu, M; Ru, J; James-Bott, A; Xiong, D; Wang, X; Cribbs, AP

AI Collection

Journal article : Review

Small molecule-mediated targeting of microRNAs for drug discovery: experiments, computational techniques, and disease implications

Abstract:: Small molecules have been providing medical breakthroughs for human diseases for more than a century. Recently, identifying small molecule inhibitors that target microRNAs (miRNAs) has gained importance, despite the challenges posed by labour-intensive screening experiments and the significant efforts required for medicinal chemistry optimization. Numerous experimentally-verified cases have demonstrated the potential of miRNA-targeted small molecule inhibitors for disease treatment. This new approach is grounded in their posttranscriptional regulation of the expression of disease-associated genes. Reversing dysregulated gene expression using this mechanism may help control dysfunctional pathways. Furthermore, the ongoing improvement of algorithms has allowed for the integration of computational strategies built on top of laboratory-based data, facilitating a more precise and rational design and discovery of lead compounds. To complement the use of extensive pharmacogenomics data in prioritising potential drugs, our previous work introduced a computational approach based on only molecular sequences. Moreover, various computational tools for predicting molecular interactions in biological networks using similarity-based inference techniques have been accumulated in established studies. However, there are a limited number of comprehensive reviews covering both computational and experimental drug discovery processes. In this review, we outline a cohesive overview of both biological and computational applications in miRNA-targeted drug discovery, along with their disease implications and clinical significance. Finally, utilizing drug-target interaction (DTIs) data from DrugBank, we showcase the effectiveness of deep learning for obtaining the physicochemical characterization of DTIs.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Sun, J., Xu, M., Ru, J., James-Bott, A., Xiong, D., Wang, X., & Cribbs, A. P. (2023). Small molecule-mediated targeting of microRNAs for drug discovery: experiments, computational techniques, and disease implications. European Journal of Medicinal Chemistry, 257.

MLA Style

Sun, J, et al. “Small Molecule-Mediated Targeting of MicroRNAs for Drug Discovery: Experiments, Computational Techniques, and Disease Implications.” European Journal of Medicinal Chemistry, vol. 257, 2023.

Chicago Style

Sun, J, M Xu, J Ru, et al. 2023. “Small Molecule-Mediated Targeting of MicroRNAs for Drug Discovery: Experiments, Computational Techniques, and Disease Implications.” European Journal of Medicinal Chemistry 257.
Print